Protective effects of Ping-Lv-Mixture (PLM), a medicinal formula on arrhythmias induced by myocardial ischemia-reperfusion

Journal of Ethnopharmacology

Volumn 108, Issue 1, 2006, Pages 90-95

  An, Wei ^a   Yang, Jing ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Herbal formula; Lipid peroxidation; Myocardial ischemia reperfusion; Platelet activating factor receptor

Indexed keywords

BELAMCANDA CHINESIS EXTRACT; CREATINE KINASE; GLYCYRRHIZA INFLATE EXTRACT; LACTATE DEHYDROGENASE; MALONALDEHYDE; MESSENGER RNA; PLANT EXTRACT; SCHISANDRA CHINENSIS EXTRACT; SOPHORA FLAVESCENS EXTRACT; SOPHORA TONKINESIS EXTRACT; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MONITORING; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL;

ANIMALS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; CREATINE KINASE; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FEMALE; GENE EXPRESSION REGULATION; L-LACTATE DEHYDROGENASE; MALE; MEDICINE, CHINESE TRADITIONAL; MYOCARDIAL REPERFUSION INJURY; PHYTOTHERAPY; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 33749328576     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.04.009     Document Type: Article

References (29)

1. Ai J., Gao H.H., He S.Z., Wang L., Luo D.L., and Yang B.F. Effects of matrine, artemisinin, tetrandrine on cytosolic [Ca2+]i in guinea pig ventricular myocytes. Acta Pharmacologica Sinica 22 (2001) 512-515
2. Bafna P.A., and Balaraman R. Anti-ulcer and antioxidant activity of DHC-1, an herbal formulation. Journal of Ethnopharmacology 90 (2004) 123-127
3. Baxter G.F., Goodwin R.W., Wright M.J., Cerac M., Heads R.J., and Yellon D.M. Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischemic properties in rabbit heart. Journal of Brain Pharmacology 117 (1996) 1685-1692
4. Carini M., Aldini G., Rossain G., Morazzoni P., and Facino R.M. Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increase in the plasma antioxidant capacity in the rat. Plantar Medicine 67 (2001) 357
5. Ferrari R., Alfieri O., Curello S., Cargononi A., and Visioli O. Occurrence of oxidative stress during reperfusion of the human heart. Circulation 81 (1990) 201-211
6. Fugh B.A. Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Preventive Cardiology 3 (2000) 24-32
7. Gino A.K., Sachu P., and Thomas V. Effect of aqueous extract of the Desmodium gangeticum DC root in the severity of myocardial infarction. Journal of Ethnopharmacology 97 (2005) 457-461
8. Hostettler M.E., and Carlson S.L. PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. Neuroreport 13 (2002) 21-24
9. Hu B., Sun S.G., Mei G.W., Chen L.Y., and Tong E.T. Protective effect of Ginkgo biloba extract on rats during cerebral ischemia-reperfusion. Chinese Medical Journal 115 (2002) 1316-1320
10. Huang L.M., Chen J.K., Lee R.S., Liang H.C., and Su M.J. Beneficial effects of Astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radical Biology and Medicine 30 (2001) 877-883
11. Ipseeta M., Dharamvir S.A., Amit D., Sujata J., Keval K.T., and Suresh K.G. Protective effects of Curcuma longa on ischemia-reperfusion induced myocardial injuries and their mechanisms. Life Sciences 75 (2004) 1701-1711
12. Ishii S., and Shimizu T. Platelet activating factor receptor and genetically engineered PAF receptor mutant mice. Journal of Lipid Research 39 (2000) 41-82
13. Jorg W.W., and Hermann N. Cardiac effects of isoliquiritigenin. European Journal of Pharmacology 326 (1997) 37-44
14. Katsuya M., Norimitsu M., Joynal A., Shigeo K., Yoshihiro N., and Toshihiro D. Development of tactile allodynia and thermal hyperalgesia by intrathecally administered platelet-activating factor in mice. Pain 111 (2004) 351-359
15. Kenichiro A., Shigeo T., Akihide N., Tsuyoshi W., and Kiyoshi K. Distribution of platelet activating factor receptor Mrna along the rat nephron segments. Biochemical and Biophysical Research Communication 225 (1996) 352-357
16. Ko K.M., and Lam B.Y. Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain. Molecular and Cellular Biochemistry 238 (2002) 181-186
17. Leong L.L.L., Sturm M.J., and Papadimitrious J.M. The effects of a PAF antagonist on ischemic myocardial damage and arrhythmias in the dogs. Journal of Molecular Cell Cardiology 24 (1992) 641-649
18. Loucks E.B., Qayumi A.K., and Godin D.V. Therapeutic potential of platelet activating factor antagonism in the management of myocardial infarction. American Journal of Medicine 16 (2000) 497-504
19. Margit P., Elizabeth R., and Gabor M. Effects of bisaramil on coronary occlusion-reperfusion injury and free radical induced reactions. Pharmacological Research 33 (1996) 327-336
20. Pragada R.R., Veeravalli K.K., Chowdary K.P.R., and Routhu K.V. Cardioprotective activity of Hydrocotyle asiatica L. in ischemia-reperfusion induced myocardial infarction in rats. Journal of Ethnopharmacology 93 (2004) 105-108
21. Qayumi A.K., English J.C., and Godin D.V. The role of platelet activating factor in regional myocardial ischemia-reperfusion injury. Clinical Chemistry 65 (1998) 1690-1697
22. Rao P.S., Ayres S.M., and Mueller H. New manual automated method for determining activity of creatine kinase isoenzyme MB, by use of dithiothreitol: clinical applications. Clinical Chemistry 21 (1975) 1612-1618
23. Romson J.L., Hook B.G., Kunkel S.S., Abrams G.D., Shork M.A., and Luchessi B.R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dogs. Circulation 67 (1983) 1016-1023
24. Serebruany V.L., Gurbel P.A., and Murugesan S.R. Depressed plasma platelet activating factor acetylhydrolase in patients presenting with acute myocardial infarction. Cardiology 90 (1998) 127-130
25. Werthamer M.S., Freiberg A., and Amaral L. Quantization of lactate dehydrogenase isoenzymes patterns of the developing human fetus. Clinica Chemica Acta 45 (1973) 5
26. Wu S., Brian L.F., and James R.P. Monophosphoryl lipid A reduces both arrhythmia severity and infarct size in a rat model of ischemia. European Journal of Pharmacology 345 (1998) 285-287
27. Xu C.Q., Dong D.L., Du Z.M., Chen Q.W., Gong D.M., and Yang B.F. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866. Yao Xue Xue Bao 39 (2004) 691-694
28. Zeng J.X., Cao H.Y., Li Q., Xu Z., and Cao Z.B. Effects of oxymatrine on arrhythmia in dogs with myocardial infarction. Zhongguo Yao Li Xue Bao 17 (1996) 379-382
29. Zhang B.H., Wang N.S., Li X.J., Kong X.J., and Cai Y.T. Anti-arrhythmic effects of matrine. Zhongguo Yao Li Xue Bao 11 (1990) 253-257